Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content
Chronic Kidney Disease Home > CKD Surveillance Home > Browse By Topic > Prevalence > Prevalence of CKD in the General Population > Age-adjusted prevalence of CKD stages 1-4

Prevalence of CKD in the General Population
 
Prevalence of CKD in the Health Care System Population
 
Prevalence of CKD Towards Tracking Healthy People 2020 Goals
Incidence of CKD in the General Population
 
Incidence of CKD in the Health Care System Population
Person Awareness of CKD
 
Provider Awareness of CKD
Diabetes in the General Population
Diabetes in the Health Care System Population
Hypertension in the General Population
Hypertension in the Health Care System Population
 
Obesity in the General Population
CVD in the General Population
Smoking in the General Population
Age in the General Population
 
Age in the Health Care System Population
Race/Ethnicity in the General Population
Race/Ethnicity in the Health Care System Population
Family History of CKD
Dialysis-requiring AKI in the General Population
Mortality in CKD in the General Population
Mortality in CKD in the Health Care System Population
 
Physical and Mental Functioning in CKD
Cardiovascular Events in CKD in the Health Care Delivery System Population
 
Mortality in CKD in the Health Care Delivery System Population
Risk Factors for Progression of CKD
Medical Expenditures
Laboratory Testing for CKD in the Health Care System
 
Nephrology Care Prior to ESRD
 
Use of Medications in CKD
Blood Pressure Treatment and Control in CKD
CKD Detection
Medication Use
Reporting of eGFR and Use of Calibrated Creatinine by U.S. Laboratories
 
Laboratory Reporting of eGFR in the Health Care System
Insurance Status in the General Population
 
Availability of Dialysis and Transplant Facilities in the United States
Number of Nephrologists and Primary Care Providers in the United States
Indicator Details


Age-Adjusted Prevalence of CKD Stages 1-4a
National Health and Nutrition Examination Survey
Slide down with Key points Key Points Pop-out page portraying Methods Used Methods Data Table Excel Download Table Chart Image Download Chart

Data Sources
 
Stratification and Year Choices:
View Data By:

View Data By:


Gender GO Gender
Race/Ethnicity GO Race/Ethnicity
Diabetes GO Diabetes
Hypertension GO Hypertension

Age-Adjusted Prevalence of CKD Stages 1-4 by Gender 1999-2012 14.76 15.93 13.52





Age-Adjusted Prevalence of CKD Stages 1-4 by Gender 1999-2012a
National Health and Nutrition Examination Survey
YearMaleFemaleTotal
1999-201213.5% (CI 12.9-14.1)15.9% (CI 15.4-16.5)14.8% (CI 14.3-15.3)

Footnotes:
a Stages 1 and 2 defined by single assessment of albuminuria (i.e., no estimation of persistence). and eGFR ≥90 and 60-89 ml/min/1.73 m², respectively; stages 3 and 4 defined as 30-59 and 15-29 ml/min/1.73 m², respectively.

Notes:
95% confidence intervals, when available, are shown in parentheses.

Suggested Citation:
Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System—United States.
website. http://www.cdc.gov/ckd


References and Sources:
  • Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247-54.
  • Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 2003;41(1):1-12.
  • Selvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis. 2007;50(6):918-26.

TOP